335 related articles for article (PubMed ID: 28689875)
1. Contribution of AcrAB-TolC to multidrug resistance in an Escherichia coli sequence type 131 isolate.
Schuster S; Vavra M; Schweigger TM; Rossen JWA; Matsumura Y; Kern WV
Int J Antimicrob Agents; 2017 Sep; 50(3):477-481. PubMed ID: 28689875
[TBL] [Abstract][Full Text] [Related]
2. The Role of AcrAB-TolC Efflux Pumps on Quinolone Resistance of E. coli ST131.
Atac N; Kurt-Azap O; Dolapci I; Yesilkaya A; Ergonul O; Gonen M; Can F
Curr Microbiol; 2018 Dec; 75(12):1661-1666. PubMed ID: 30283991
[TBL] [Abstract][Full Text] [Related]
3. The 2019 Garrod Lecture: MDR efflux in Gram-negative bacteria-how understanding resistance led to a new tool for drug discovery.
Piddock LJV
J Antimicrob Chemother; 2019 Nov; 74(11):3128-3134. PubMed ID: 31626705
[TBL] [Abstract][Full Text] [Related]
4. Genetic evidence for functional interactions between TolC and AcrA proteins of a major antibiotic efflux pump of Escherichia coli.
Gerken H; Misra R
Mol Microbiol; 2004 Nov; 54(3):620-31. PubMed ID: 15491355
[TBL] [Abstract][Full Text] [Related]
5. AcrB-AcrA Fusion Proteins That Act as Multidrug Efflux Transporters.
Hayashi K; Nakashima R; Sakurai K; Kitagawa K; Yamasaki S; Nishino K; Yamaguchi A
J Bacteriol; 2016 Jan; 198(2):332-42. PubMed ID: 26527645
[TBL] [Abstract][Full Text] [Related]
6. Mapping the Role of AcrAB-TolC Efflux Pumps in the Evolution of Antibiotic Resistance Reveals Near-MIC Treatments Facilitate Resistance Acquisition.
Langevin AM; El Meouche I; Dunlop MJ
mSphere; 2020 Dec; 5(6):. PubMed ID: 33328350
[TBL] [Abstract][Full Text] [Related]
7. Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump.
Grimsey EM; Fais C; Marshall RL; Ricci V; Ciusa ML; Stone JW; Ivens A; Malloci G; Ruggerone P; Vargiu AV; Piddock LJV
mBio; 2020 Jun; 11(3):. PubMed ID: 32487753
[TBL] [Abstract][Full Text] [Related]
8. Total alkaloids of Sophorea alopecuroides-induced down-regulation of AcrAB-TolC efflux pump reverses susceptibility to ciprofloxacin in clinical multidrug resistant Escherichia coli isolates.
Zhou X; Jia F; Liu X; Wang Y
Phytother Res; 2012 Nov; 26(11):1637-43. PubMed ID: 22371352
[TBL] [Abstract][Full Text] [Related]
9. Limited Multidrug Resistance Efflux Pump Overexpression among Multidrug-Resistant Escherichia coli Strains of ST131.
Camp J; Schuster S; Vavra M; Schweigger T; Rossen JWA; Reuter S; Kern WV
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468485
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics Reveal Potential Natural Substrates of AcrB in Escherichia coli and Salmonella enterica Serovar Typhimurium.
Wang-Kan X; Rodríguez-Blanco G; Southam AD; Winder CL; Dunn WB; Ivens A; Piddock LJV
mBio; 2021 Mar; 12(2):. PubMed ID: 33785633
[TBL] [Abstract][Full Text] [Related]
11. Drug Efflux Pump Inhibitors: A Promising Approach to Counter Multidrug Resistance in Gram-Negative Pathogens by Targeting AcrB Protein from AcrAB-TolC Multidrug Efflux Pump from
Alenazy R
Biology (Basel); 2022 Sep; 11(9):. PubMed ID: 36138807
[TBL] [Abstract][Full Text] [Related]
12. Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops.
Elkins CA; Nikaido H
J Bacteriol; 2002 Dec; 184(23):6490-8. PubMed ID: 12426336
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of VceC gain-of-function mutants that can function with the AcrAB multiple-drug-resistant efflux pump of Escherichia coli.
Vediyappan G; Borisova T; Fralick JA
J Bacteriol; 2006 Jun; 188(11):3757-62. PubMed ID: 16707668
[TBL] [Abstract][Full Text] [Related]
14. Escherichia coli resistance mechanism AcrAB-TolC efflux pump interactions with commonly used antibiotics: a molecular dynamics study.
Smith BL; Fernando S; King MD
Sci Rep; 2024 Feb; 14(1):2742. PubMed ID: 38302495
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance pump AcrAB-TolC is required for high-level, Tet(A)-mediated tetracycline resistance in Escherichia coli.
de Cristóbal RE; Vincent PA; Salomón RA
J Antimicrob Chemother; 2006 Jul; 58(1):31-6. PubMed ID: 16687460
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives.
Sjuts H; Vargiu AV; Kwasny SM; Nguyen ST; Kim HS; Ding X; Ornik AR; Ruggerone P; Bowlin TL; Nikaido H; Pos KM; Opperman TJ
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3509-14. PubMed ID: 26976576
[TBL] [Abstract][Full Text] [Related]
17. Interactions underlying assembly of the Escherichia coli AcrAB-TolC multidrug efflux system.
Touzé T; Eswaran J; Bokma E; Koronakis E; Hughes C; Koronakis V
Mol Microbiol; 2004 Jul; 53(2):697-706. PubMed ID: 15228545
[TBL] [Abstract][Full Text] [Related]
18. Small RNA Regulation of TolC, the Outer Membrane Component of Bacterial Multidrug Transporters.
Parker A; Gottesman S
J Bacteriol; 2016 Jan; 198(7):1101-13. PubMed ID: 26811318
[TBL] [Abstract][Full Text] [Related]
19. Simulated microgravity affects ciprofloxacin susceptibility and expression of acrAB-tolC genes in E. coli ATCC25922.
Xu B; Li C; Zheng Y; Si S; Shi Y; Huang Y; Zhang J; Cui Y; Cui Y
Int J Clin Exp Pathol; 2015; 8(7):7945-52. PubMed ID: 26339360
[TBL] [Abstract][Full Text] [Related]
20. AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity.
Blair JM; Bavro VN; Ricci V; Modi N; Cacciotto P; Kleinekathӧfer U; Ruggerone P; Vargiu AV; Baylay AJ; Smith HE; Brandon Y; Galloway D; Piddock LJ
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3511-6. PubMed ID: 25737552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
